Free Trial

Aspen Aerogels (NYSE:ASPN) Sets New 1-Year Low - Here's What Happened

Aspen Aerogels logo with Construction background
Remove Ads

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report)'s stock price hit a new 52-week low during trading on Friday . The company traded as low as $6.55 and last traded at $6.60, with a volume of 1933584 shares trading hands. The stock had previously closed at $6.95.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Roth Mkm reduced their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a research report on Wednesday, February 19th. Canaccord Genuity Group decreased their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. Seaport Res Ptn downgraded Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. Finally, B. Riley decreased their price objective on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a report on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $19.11.

View Our Latest Report on Aspen Aerogels

Remove Ads

Aspen Aerogels Price Performance

The company has a 50 day simple moving average of $8.92 and a 200 day simple moving average of $14.52. The company has a market capitalization of $523.42 million, a price-to-earnings ratio of 39.85 and a beta of 2.28. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, research analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.

Hedge Funds Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently bought and sold shares of the stock. Abbot Financial Management Inc. lifted its position in shares of Aspen Aerogels by 3.9% during the fourth quarter. Abbot Financial Management Inc. now owns 30,255 shares of the construction company's stock worth $359,000 after purchasing an additional 1,146 shares in the last quarter. Franklin Resources Inc. increased its stake in Aspen Aerogels by 5.3% during the 3rd quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company's stock worth $815,000 after buying an additional 1,483 shares during the period. Invesco Ltd. lifted its holdings in Aspen Aerogels by 3.5% in the 4th quarter. Invesco Ltd. now owns 50,871 shares of the construction company's stock worth $604,000 after buying an additional 1,724 shares in the last quarter. Greenwood Capital Associates LLC boosted its position in Aspen Aerogels by 5.0% in the 4th quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company's stock valued at $439,000 after buying an additional 1,749 shares during the last quarter. Finally, MetLife Investment Management LLC grew its stake in shares of Aspen Aerogels by 6.3% during the fourth quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company's stock valued at $425,000 after acquiring an additional 2,118 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Read More

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Congress Bought THESE Stocks as Tariffs Tanked the Market

Congress Bought THESE Stocks as Tariffs Tanked the Market

Reports of congressional buying and selling during the tariff meltdown are coming in; find out which companies members of Congress bought and sold.

Related Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
Donald Trump Owns These 7 Stocks, Should You?
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads